Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PAR-19-220
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $650,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Special District Governments
- State Governments
- 501(c)(3) Nonprofits
- Other
- Non-501(c)(3) Nonprofits
- City/Township Governments
- County Governments
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Private)
- For Profit Organizations
- Independent School Districts
- Small Businesses
- Tribal Organizations (Not Federally Recognized)
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical studies that address critical needs for clinical trial readiness in rare neurological and neuromuscular diseases. These studies should result in clinically validated biomarkers and clinical outcome assessment measures appropriate for use in upcoming clinical trials. Through the support of trial readiness studies, NINDS and NCATS expect to enhance the quality and increase the likelihood of success of clinical trials in these rare diseases.
Files
| File | Type | Posted |
|---|---|---|
| PAR-19-220-Full-Announcement.html | HTML file | |
| PKG00249016-instructions.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity